FDA Approved: ONIVYDE — Original Application (Ipsen Biopharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ONIVYDE (irinotecan hydrochloride liposome injection) under the Original Application from Ipsen Biopharmaceuticals, Inc., for pancreatic cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

ORIG AP for ONIVYDE (IRINOTECAN HYDROCHLORIDE)